Phase 1 dose-escalation study of the antiplacental growth factor monoclonal antibody RO5323441 combined with bevacizumab in patients with recurrent glioblastoma

Ulrik Lassen, Olivier L Chinot, Catherine McBain, Morten Mau-Sørensen, Vibeke Andrée Larsen, Maryline Barrie, Patrick Roth, Oliver Krieter, Ka Wang, Kai Habben, Jean Tessier, Angelika Lahr, Michael Weller

26 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Phase 1 dose-escalation study of the antiplacental growth factor monoclonal antibody RO5323441 combined with bevacizumab in patients with recurrent glioblastoma'. Together they form a unique fingerprint.

Medicine & Life Sciences